Published in Proc Natl Acad Sci U S A on April 01, 1984
Membrane biogenesis during B cell differentiation: most endoplasmic reticulum proteins are expressed coordinately. J Cell Biol (1990) 1.74
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways. Mol Cell Biol (1990) 1.00
Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci U S A (1985) 0.99
Expression of intracisternal A-type particles is increased when a B-cell lymphoma differentiates into an immunoglobulin-secreting cell. J Virol (1989) 0.81
Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology (1968) 24.83
A theory of self-nonself discrimination. Science (1970) 7.99
T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci U S A (1980) 3.08
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors. Proc Natl Acad Sci U S A (1981) 2.74
Specific T helper cells that activate B cells polyclonally. In vitro enrichment and cooperative function. J Exp Med (1980) 2.27
Antigen-specific T-helper cells stimulate H-2-compatible and H-2-incompatible B-cell blasts polyclonally. J Exp Med (1980) 1.85
Dissociation of two signals required for activation of resting B cells. Proc Natl Acad Sci U S A (1982) 1.74
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
Positive and negative allogeneic effects mediated by MLR-primed lymphocytes: quantitation by limiting dilution analysis. J Immunol (1978) 1.37
Major histocompatibility complex-restricted cellular interactions determining B cell activation. Eur J Immunol (1982) 1.30
The properties of plaque-forming cells from autoimmune and normal strains of mice with specificity for autologous erythrocyte antigens. J Immunol (1975) 1.25
Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics (1982) 1.23
The regulation of T cell growth: requirements for the activation and replication of antigen-specific interleukin 2 producing T cells. Immunobiology (1982) 1.08
The purified protein derivative of turberculin, a B-cell mitogen that distinguishes in its action resting, small B cells from activated B-cell blasts. J Exp Med (1979) 1.02
Definition of conditions that enable antigen-specific activation of the majority of isolated trinitrophenol-binding B cells. J Exp Med (1982) 1.01
Limiting dilution analysis of the suppressive effect mediated by alloantigen-primed cells. Immunology (1980) 0.92
In vivo responses of alloreactive lymphocytes stimulated in vitro. Helper-cell activity of MLR-primed lymphocytes. Scand J Immunol (1977) 0.92
Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol (1992) 3.39
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. J Natl Cancer Inst (1966) 1.61
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc Natl Acad Sci U S A (1986) 1.46
Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med (1986) 1.43
High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. J Immunol (1990) 1.43
Positive and negative allogeneic effects mediated by MLR-primed lymphocytes: quantitation by limiting dilution analysis. J Immunol (1978) 1.37
Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci. J Exp Med (1991) 1.34
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
B-1 cells are made, not born. Immunol Today (1993) 1.32
Novel type of murine B-cell lymphoma. Nature (1978) 1.29
Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics (1982) 1.23
Cytolysis of mouse lymph node cells by alloantibody: a comparison of guinea-pig and rabbit complements. Immunology (1969) 1.22
Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9. J Immunol (1990) 1.22
Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med (1989) 1.20
Major histocompatibility complex-restricted recognition of retroviral superantigens by V beta 17+ T cells. J Exp Med (1992) 1.16
Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. Bioessays (1998) 1.11
Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol (1978) 1.11
The regulation of T cell growth: requirements for the activation and replication of antigen-specific interleukin 2 producing T cells. Immunobiology (1982) 1.08
B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06
Production, testing, and utility of double congenic strains of mice.I. B10 H-2aa=H-48P-wis and Bio-H-4BP-Wis. Transplantation (1974) 1.02
Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol (1996) 1.02
Direct evidence that J chain regulates the polymeric structure of IgM in antibody-secreting B cells. J Biol Chem (1992) 1.01
Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther (1996) 1.01
HL-A-linked human immune-response genes. Proc Natl Acad Sci U S A (1973) 1.01
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
The murine kappa light chain shift. Nature (1978) 1.01
Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways. Mol Cell Biol (1990) 1.00
Naturally occurring soluble H-2 specificity in mouse tissues. Immunology (1965) 1.00
Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM. J Immunol (1998) 0.99
Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci U S A (1985) 0.99
Transplantation antigen of mice: cellular localization of antigen determined by the H-2 locus. Transplantation (1966) 0.98
Molecular events during B lymphocyte differentiation. Induction of endogenous mouse mammary tumor proviral envelope transcripts after B cell stimulation. J Immunol (1988) 0.98
Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J Exp Med (1991) 0.98
Characterization of a presecretory phase in B-cell differentiation. Proc Natl Acad Sci U S A (1989) 0.97
Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. J Immunol (1978) 0.97
Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast. J Natl Cancer Inst (1976) 0.97
The male antigen. II. Regulation of the primary and secondary responses to H-Y by H-2 associated genes. Cell Immunol (1974) 0.97
The biological effects of IgM hexamer formation. Eur J Immunol (1990) 0.95
Mechanism and subcellular localization of secretory IgM polymer assembly. J Biol Chem (1994) 0.94
J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5. Proc Natl Acad Sci U S A (1992) 0.94
H-2 control of expression of an idiotype shared by normal B cells and a B-cell lymphoma. Immunogenetics (1985) 0.94
Suppression or augmentation of the antihapten response in mice by antibodies of different specificities. J Exp Med (1973) 0.94
MHC class II limits the functional expression of endogenous superantigens in B cells. J Immunol (1993) 0.93
Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther (1994) 0.93
Specific immunosuppression by minute doses of passive antibody. II. The site of action. J Reticuloendothel Soc (1970) 0.93
In vivo responses of alloreactive lymphocytes stimulated in vitro. Helper-cell activity of MLR-primed lymphocytes. Scand J Immunol (1977) 0.92
Limiting dilution analysis of the suppressive effect mediated by alloantigen-primed cells. Immunology (1980) 0.92
Induced differentiation of a B cell lymphoma with known antigen specificity. J Mol Cell Immunol (1984) 0.92
A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells. J Immunol (2001) 0.91
Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice. J Natl Cancer Inst (1971) 0.91
Chromosome 15 trisomy in spontaneous and carcinogen-induced murine lymphomas of B-cell origin. Int J Cancer (1981) 0.90
Lymphoma growth in vivo: electronic discrimination between tumor and stroma cells. Science (1965) 0.89
The contribution of ER quality control to the biologic functions of secretory IgM. Immunol Today (1999) 0.89
Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response. Ann N Y Acad Sci (1992) 0.89
Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum. J Immunol (1980) 0.89
Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation. J Immunol (1999) 0.88
Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology (2001) 0.87
Quantitation of cell surface molecules on a differentiating, Ly-1+ B cell lymphoma. J Immunol (1987) 0.87
Antigenic cross-reactivity between benign and malignant neoplasms of the human breast. J Natl Cancer Inst (1974) 0.86
A T cell-replacing factor specific for histocompatibility antigens in mice. Nature (1977) 0.86
Ig isotype switching in B lymphocytes. The effect of T cell-derived interleukins, cytokines, cholera toxin, and antigen on isotype switch frequency of a cloned B cell lymphoma. Int Immunol (1991) 0.86
Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation. Mol Cell Biol (1993) 0.86
Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricular hypertrophy in sheep. Circulation (1999) 0.85
IgM hexamers? Immunol Today (1994) 0.85
Lymphocyte stimulation in vitro: generation of cytotoxic effector lymphocytes using subcellular fractions of a lymphoid cell line. Cell Immunol (1975) 0.85
Specific immunosuppression by passive antibody. V. Participation of macrophages in reversal of suppression by peritoneal exudate cells from immune animals. Cell Immunol (1974) 0.84
In vivo responses of alloreactive lymphocytes stimulated in vitro. Skin graft rejection mediated by MLR-Primed lymphocytes. Scand J Immunol (1977) 0.84
Quality control in protein biogenesis: thiol-mediated retention monitors the redox state of proteins in the endoplasmic reticulum. J Cell Sci (1996) 0.84
Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM. J Immunol (1988) 0.84
Specific immunosuppression by minute doses of passive antibody. Transplant Proc (1969) 0.84
Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. Int Immunol (1993) 0.83
Ratio-dominance model of suppression: an analysis by limiting dilution. Immunology (1980) 0.83
Specific immunosuppression by minute doses of passive antibody. 3. Reversal of suppression by peritoneal exudate cells from immune animals. Cell Immunol (1971) 0.83
Secretion of soluble pre-B cell receptors by pre-B cells. J Immunol (1997) 0.83
Correlation of antibody multireactivity with variable region primary structure among murine anti-erythrocyte autoantibodies. Eur J Immunol (1992) 0.83